Application of the International Classification of Diseases to Neurology \ Second Edition

Total Page:16

File Type:pdf, Size:1020Kb

Application of the International Classification of Diseases to Neurology \ Second Edition Application of the International Classification of Diseases to Neurology \ Second Edition World Health Organization Geneva 1997 First edition 1987 Second edition 1997 Application of the international classification of diseases to neurology: ICD-NA- 2nd ed. 1. Neurology - classification 2. Nervous system diseases - classification I. Title: ICD-NA ISBN 92 4 154502 X (NLM Classification: WL 15) The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. ©World Health Organization 1997 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. Typeset in Hong Kong Printed in Canada 95/10663-Best-set/Tri-Graphics-8000 Contents Preface v Acknowledgements vii Section I Introduction 1 Section II Instructions and recommendations for the use of ICD-NA 13 Section III List of block titles 19 Section IV Tabular list of neurological and related disorders 31 Section V Morphology of neoplasms 459 Index 477 Table of drugs and chemicals 565 iii Preface The Application of the International Classification of Diseases to Neurology (ICD-NA) is one of several adaptations of the Tenth Revision of the Interna­ tional Statistical Classification of Diseases and Related Health Problems (ICD-10) being produced by the World Health Organization to respond to the needs of specialist disciplines such as neurology. A previous edition of ICD-NA was developed in 1984-85 with the help of a group of experts convened by Dr L. Bolis (International Foundation Fatebenefratelli, Milan, Italy), then in charge of activities dealing with the prevention and control of neurological disorders in WHO's Division of Mental Health (MNH). Taking into account the recommendations of this expert group and advice received from the Neuroepidemiology Group of the World Federation of Neurology, chaired by the late Professor B.S. Schoenberg (National Institutes of Health, Bethesda, MD) and from other nongovernmental organizations, Professor J.-M. Orgogozo and Professor J.F. Dartigues (University of Bordeaux, France) drafted the text of the first edition in English and French. That edition provided an extensive selection, but a limited expansion, of the neurologically relevant codes of ICD-9. The present edition has been developed with the broader aim of providing an individual code for almost every neurological condition, so that a uniform classification is available for epidemiological and clinical research as well as for routine statistical reporting. The synopsis of the second edition of ICD-NA was produced by Professor W.G. Bradley (University of Miami, Miami, FL), Professor J.-M. Orgogozo, Dr N. Sartorius (then Director of WHO's Division of Mental Health) and Dr J. van Drimmelen (WHO, Geneva, Switzerland). It was discussed with repre­ sentatives of nongovernmental organizations active in the field of neurology and with experts in WHO and from various Member countries and then used as a framework for the development of the ICD-NA. The initial draft of ICD-NA was produced by Professors Bradley and Orgogozo with the help of Dr van Drimmelen on the basis of the first edition and of detailed suggestions from the Ad Hoc Committee on Disease Clas­ sification of the American Neurological Association, chaired by Professor Bradley; in the Acknowledgements section (pages ix-xii), the names of the members of the committee are marked with an asterisk. The draft was exam­ ined by nongovernmental organizations active in the field of neurology (listed on page xi) and by numerous advisers. Their valuable comments contributed v ICD-NA to the production of the penultimate version of ICD-NA, which was again reviewed by the participating nongovernmental organizations. The final version reflects the best resolution of many, often competing, needs. It should be kept in mind that ICD-NA had to be based upon the structure of ICD-10. This has prevented the introduction of some changes that were recommended, but has ensured that all of the 5-, 6- and ?-character codes of the ICD-NA can be contracted back into the original 3- or 4-character codes of ICD-10; compatibility with the official classification can therefore be main­ tained, whatever the purpose or level of utilization. The ICD-NA index was produced by Mr M. Catan and Dr van Drimmelen of WHO, using a preliminary partial draft produced by Drs H.J. Freyberger and C. Kessler (Liibeck, Germany), with extensive help from Mr A. L'Hours of WHO's Division of Health Situation and Trend Assessment. Guidance from Mr l'Hours also helped to ensure the congruence of ICD-NA with the parent ICD-10. An outline of the history of the International Classification of Diseases, infor­ mation on the structure of ICD-NA and instructions on its use are given in Sections I and II of this publication. Dr N.P. Napalkov Assistant Director-General World Health Organization vi Acknowledgements The following organizations provided invaluable support to the development of this publication: American Academy of Neurology American Neurological Association American Sleep Disorders Association European Federation of Neurological Societies European Stroke Council International Brain Research Organization International Bureau for Epilepsy International Cerebral Palsy Society International Child Neurology Association International Federation of Multiple Sclerosis Societies International Headache Society International League Against Epilepsy International Movement Disorder Society International Society of Neuropathology International Stroke Society World Federation for Mental Health World Federation of Neurology World Federation of Neurosurgical Societies Special thanks are due to Lord Walton of Detchant, whose continuing and strong support greatly facilitated the work on this publication, and to Professor Armand Lowenthal, of the World Federation of Neurology (WFN), who was particularly helpful in obtaining comments from Committees and Research Groups of the World Federation of Neurology. Administrative support for this work was provided by Ms J. Gilmore, Mrs J. Joseph and Mrs T. Drouillet. The work done by the following individuals, whose comments were particularly helpful and thoughtful, is gratefully acknowledged. Members of the Ad Hoc Committee on Neurological Classification of the American Neurological Association are indicated with an asterisk (*). *Dr R. Ackerman, Boston, MA, USA *Dr H. Adams, Glasgow, Scotland vii ICD-NA Dr Y. Agid, Paris, France Dr A. Ahmed, Karachi, Pakistan Dr L. Amaducci, Florence, Italy DrS. Araki, Kumamoto, Japan *Dr B. Amason, Chicago, IL, USA *Dr J. Bale, Iowa City, lA, USA *Dr B. Banker, Hanover, Germany Sir Roger Bannister, Oxford, England Dr B. Barac, Zagreb, Croatia Dr H. Barnett, London, Ontario, Canada *Dr R.W. Beck, Tampa, FL, USA *Dr W. Bell, Iowa City, lA, USA *Dr D.F. Benson, Los Angeles, CA, USA Dr A. Beraldelli, Rome, Italy *Dr J. Berger, Miami, FL, USA Dr N.E. Bharucha, Bombay, India Dr K.L. Bick, Washington, DC, USA Dr C.D. Binnie, London, England *Dr P. Black, Boston, MA, USA Dr J.P. Blass, New York, NY, USA *Dr J. Blavis, New York, NY, USA Dr J. Bogousslavsky, Lausanne, Switzerland *Dr W.G. Bradley, Miami, FL, USA *Dr B. Brookes, Madison, WI, USA *Dr J. Bruni, Mississauga, Ontario, Canada *Dr L. Caplan, Boston, MA, USA Dr P. Casaer, Louvain, Belgium Dr J.-P. Castel, Bordeaux, France *Dr M. Cohen, Buffalo, NY, USA *Dr M. Cole, Mayfield Heights, OH, USA *Dr P. Cooper, London, Ontario, Canada Dr R. Currier, Jackson, MS, USA *Dr D. Dalessio, La Jolla, CA, USA *Dr A. Damasio, Iowa City, lA, USA Dr J.P. Dartigues, Bordeaux, France *Dr J. Daube, Rochester, MN, USA Dr D .E. Deisenhammer, Vienna, Austria *Dr R. DeLorenzo, Richmond, VA, USA *Dr S. Diamond, Chicago, IL, USA *Dr R. Dorwart, Burlington, VT, USA *Dr D. Drachman, Worcester, MA, USA Dr C. Dravet, Marseilles, France *Dr F.E. Dreifuss, Charlottesville, VA, USA *Dr R. Duvoisin, New Brunswick, NJ, USA viii ACKNOWLEDGEMENTS *Dr P. Dyck, Rochester, MN, USA *Dr A.G. Engel, Rochester, MN, USA *Dr O.B. Evans, Jackson, MS, USA *DrS. Fahn, New York, NY, USA Dr N. Fejerman, Buenos Aires, Argentina *Dr R. Feldman, Boston, MA, USA *Dr G. Fenichel, Nashville, TN, USA *Dr P. Finelli, Providence, RI, USA *Dr R.A. Fishman, San Francisco, CA, USA Dr S. Flache, Geneva, Switzerland Dr D. Gardner-Medwin, Newcastle-upon-Tyne, England Dr C. Goetz, Chicago, IL, USA *Dr M. Gomez, Rochester, MN, USA *Dr B. Griggs, Rochester, MN, USA *Dr C. Gross, Burlington, VT, USA *Dr A. Harding, London, England Dr 0. Henriksen, Sandvika, Norway Dr P. Henry, Bordeaux, France Dr A. Huber, Zurich, Switzerland *Dr J.T. Hughes, Oxford, England *Dr C. J ablecki, San Diego, CA, USA Dr P. Jallon, Geneva, Switzerland Dr J. Jancovic, Houston, TX, USA *Dr P.J. Janetta, Pittsburgh, PA, USA Dr F.R. Jeri, Lima, Peru *Dr R.T. Johnson, Baltimore, MD, USA *Dr B. Katzman, La Jolla, CA, USA Dr J. Kesselring, Bad Ragaz, Switzerland *Dr A.
Recommended publications
  • Approach to a Case of Congenital Heart Disease
    BAI JERBAI WADIA HOSPITAL FOR CHILDREN PEDIATRIC CLINICS FOR POST GRADUATES PREFACE This book is a compilation of the discussions carried out at the course for post-graduates on ” Clinical Practical Pediatrics” at the Bai Jerbai Wadia Hospital for Children, Mumbai. It has been prepared by the teaching faculty of the course and will be a ready-reckoner for the exam-going participants. This manual covers the most commonly asked cases in Pediatric Practical examinations in our country and we hope that it will help the students in their practical examinations. An appropriately taken history, properly elicited clinical signs, logical diagnosis with the differential diagnosis and sound management principles definitely give the examiner the feeling that the candidate is fit to be a consultant of tomorrow. Wishing you all the very best for your forthcoming examinations. Dr.N.C.Joshi Dr.S.S.Prabhu Program Directors. FOREWARD I am very happy to say that the hospital has taken an initiative to organize this CME for the postgraduate students. The hospital is completing 75 years of its existence and has 2 done marvelous work in providing excellent sevices to the children belonging to the poor society of Mumbai and the country. The hospital gets cases referred from all over the country and I am proud to say that the referrals has stood the confidence imposed on the hospital and its faculty. We do get even the rarest of the rare cases which get diagnosed and treated. I am sure all of you will be immensely benefited by this programme. Wish you all the best in your examination and career.
    [Show full text]
  • ICD10 Diagnoses FY2018 AHD.Com
    ICD10 Diagnoses FY2018 AHD.com A020 Salmonella enteritis A5217 General paresis B372 Candidiasis of skin and nail A040 Enteropathogenic Escherichia coli A523 Neurosyphilis, unspecified B373 Candidiasis of vulva and vagina infection A528 Late syphilis, latent B3741 Candidal cystitis and urethritis A044 Other intestinal Escherichia coli A530 Latent syphilis, unspecified as early or B3749 Other urogenital candidiasis infections late B376 Candidal endocarditis A045 Campylobacter enteritis A539 Syphilis, unspecified B377 Candidal sepsis A046 Enteritis due to Yersinia enterocolitica A599 Trichomoniasis, unspecified B3781 Candidal esophagitis A047 Enterocolitis due to Clostridium difficile A6000 Herpesviral infection of urogenital B3789 Other sites of candidiasis A048 Other specified bacterial intestinal system, unspecified B379 Candidiasis, unspecified infections A6002 Herpesviral infection of other male B380 Acute pulmonary coccidioidomycosis A049 Bacterial intestinal infection, genital organs B381 Chronic pulmonary coccidioidomycosis unspecified A630 Anogenital (venereal) warts B382 Pulmonary coccidioidomycosis, A059 Bacterial foodborne intoxication, A6920 Lyme disease, unspecified unspecified unspecified A7740 Ehrlichiosis, unspecified B387 Disseminated coccidioidomycosis A080 Rotaviral enteritis A7749 Other ehrlichiosis B389 Coccidioidomycosis, unspecified A0811 Acute gastroenteropathy due to A879 Viral meningitis, unspecified B399 Histoplasmosis, unspecified Norwalk agent A938 Other specified arthropod-borne viral B440 Invasive pulmonary
    [Show full text]
  • Basilar Artery and Its Branches Called Pontine Arteries
    3 Farah Mohammad Ahmad Al-Tarefe Mohammad Al salem تذكر أ َّن : أولئك الذين بداخلهم شيء يفوق كل الظروف ، هم فقط من استطاعوا أ ّن يحققوا انجازاً رائعاً .... كن ذا همة Recommendation: Study this sheet after you finish the whole anatomy material . Dr.Alsalem started talking about the blood supply for brain and spinal cord which are mentioned in sheet#5 so that we didn't write them . 26:00-56:27/ Rec.Lab#3 Let start : Medulla oblengata : we will study the blood supply in two levels . A- Close medulla (central canal) : It is divided into four regions ; medial , anteromedial , posteriolateral and posterior region. Medially : anterior spinal artery. Anteromedial: vertebral artery posterolateral : posterior inferior cerebellar artery ( PICA). Posterior : posterior spinal artery which is a branch from PICA. B-Open medulla ( 4th ventricle ) : It is divided into four regions ; medial , anteromedial , posteriolateral region. Medially : anterior spinal artery. Anteromedial: vertebral artery posterolateral : posterior inferior cerebellar artery ( PICA). 1 | P a g e Lesions: 1- Medial medullary syndrome (Dejerine syndrome): It is caused by a lesion in anterior spinal artery which supplies the area close to the mid line. Symptoms: (keep your eyes on right pic). Contralateral hemiparesis= weakness: the pyramid will be affected . Contralateral loss of proprioception , fine touch and vibration (medial lemniscus). Deviation of the tongue to the ipsilateral side when it is protruded (hypoglossal root or nucleus injury). This syndrome is characterized by Alternating hemiplegia MRI from Open Medulla (notice the 4th ventricle) Note :The Alternating hemiplegia means ; 1- The upper and lower limbs are paralyzed in the contralateral side of lesion = upper motor neuron lesion .
    [Show full text]
  • Newborn Screening for X-Linked Adrenoleukodystrophy: Information for Parents
    Newborn Screening for X-linked Adrenoleukodystrophy: Information for Parents Baby girl with ABCD1 gene mutation What is newborn screening? the symptoms of ALD during childhood. Rarely, some women who are carriers of ALD develop mild symptoms as adults. It Newborn screening involves laboratory testing on a small is important for your family to meet with a genetic counselor sample of blood collected from newborns’ heels. Every state to talk about the genetics of ALD and implications for other has a newborn screening program to identify infants with rare family members. disorders, which would not usually be detected at birth. Early diagnosis and treatment of these disorders often prevents Why do only boys have ALD? serious complications. Only boys have ALD because it is caused by a mutation in What is adrenoleukodystrophy (ALD)? a gene (ABCD1) on the X chromosome, called “X-linked inheritance.” Males only have one X chromosome so they have ALD is one of over 40 disorders included in newborn screening one ABCD1 gene. Males with a nonfunctioning ABCD1 gene in New York State. It is a rare genetic disorder. People with have ALD. Females have 2 X chromosomes, so they have two ALD are unable to breakdown a component of food called ABCD1 genes. Females with one ABCD1 gene mutation will very long chain fatty acids (VLCFA). If VLCFA are not broken be carriers. When a mother is a carrier of ALD, each son has a down, they build up in the body and cause symptoms. 50% chance of inheriting the disorder and each daughter has a 50% chance of being a carrier.
    [Show full text]
  • Diagnostic Code Descriptions (ICD9)
    INFECTIONS AND PARASITIC DISEASES INTESTINAL AND INFECTIOUS DISEASES (001 – 009.3) 001 CHOLERA 001.0 DUE TO VIBRIO CHOLERAE 001.1 DUE TO VIBRIO CHOLERAE EL TOR 001.9 UNSPECIFIED 002 TYPHOID AND PARATYPHOID FEVERS 002.0 TYPHOID FEVER 002.1 PARATYPHOID FEVER 'A' 002.2 PARATYPHOID FEVER 'B' 002.3 PARATYPHOID FEVER 'C' 002.9 PARATYPHOID FEVER, UNSPECIFIED 003 OTHER SALMONELLA INFECTIONS 003.0 SALMONELLA GASTROENTERITIS 003.1 SALMONELLA SEPTICAEMIA 003.2 LOCALIZED SALMONELLA INFECTIONS 003.8 OTHER 003.9 UNSPECIFIED 004 SHIGELLOSIS 004.0 SHIGELLA DYSENTERIAE 004.1 SHIGELLA FLEXNERI 004.2 SHIGELLA BOYDII 004.3 SHIGELLA SONNEI 004.8 OTHER 004.9 UNSPECIFIED 005 OTHER FOOD POISONING (BACTERIAL) 005.0 STAPHYLOCOCCAL FOOD POISONING 005.1 BOTULISM 005.2 FOOD POISONING DUE TO CLOSTRIDIUM PERFRINGENS (CL.WELCHII) 005.3 FOOD POISONING DUE TO OTHER CLOSTRIDIA 005.4 FOOD POISONING DUE TO VIBRIO PARAHAEMOLYTICUS 005.8 OTHER BACTERIAL FOOD POISONING 005.9 FOOD POISONING, UNSPECIFIED 006 AMOEBIASIS 006.0 ACUTE AMOEBIC DYSENTERY WITHOUT MENTION OF ABSCESS 006.1 CHRONIC INTESTINAL AMOEBIASIS WITHOUT MENTION OF ABSCESS 006.2 AMOEBIC NONDYSENTERIC COLITIS 006.3 AMOEBIC LIVER ABSCESS 006.4 AMOEBIC LUNG ABSCESS 006.5 AMOEBIC BRAIN ABSCESS 006.6 AMOEBIC SKIN ULCERATION 006.8 AMOEBIC INFECTION OF OTHER SITES 006.9 AMOEBIASIS, UNSPECIFIED 007 OTHER PROTOZOAL INTESTINAL DISEASES 007.0 BALANTIDIASIS 007.1 GIARDIASIS 007.2 COCCIDIOSIS 007.3 INTESTINAL TRICHOMONIASIS 007.8 OTHER PROTOZOAL INTESTINAL DISEASES 007.9 UNSPECIFIED 008 INTESTINAL INFECTIONS DUE TO OTHER ORGANISMS
    [Show full text]
  • Klinefelter, Turner & Down Syndrome
    Klinefelter, Turner & Down Syndrome A brief discussion of gamete forma2on, Mitosis and Meiosis: h7ps://www.youtube.com/watch?v=zGVBAHAsjJM Non-disjunction in Meiosis: • Nondisjunction "not coming apart" is the failure of a chromosome pair to separate properly during meiosis 1, or of two chromatids of a chromosome to separate properly during meiosis 2 or mitosis. • Can effect each pair. • Not a rare event. • As a result, one daughter cell has two chromosomes or two chromatids and the other has none • The result of this error is ANEUPLOIDY. 4 haploid gametes 2 gametes with diploid 2 gametes with haploid number of x and 2 lacking number of X chromosome, 1 x chromosome gamete with diploid number of X chromosome, and 1 gamete lacking X chromosome MEIOSIS MITOSIS Nondisjunc2on at meiosis 1 = All gametes will be abnormal Nondisjunc2on at meiosis 2 = Half of the gametes are normal (%50 normal and %50 abnormal) Down’s Syndrome • Karyotype: 47, XY, +21 Three copies of chromosome 21 (21 trisomy) • The incidence of trisomy 21 rises sharply with increasing maternal age (above 37), but Down syndrome can also be the result of nondisjunction of the father's chromosome 21 (%15 of cases) • A small proportion of cases is mosaic* and probably arise from a non-disjunction event in early zygotic division. *“Mosaicism, used to describe the presence of more than one type of cells in a person. For example, when a baby is born with Down syndrome, the doctor will take a blood sample to perform a chromosome study. Typically, 20 different cells are analyzed.
    [Show full text]
  • Educational Achievement and Economic Self-Sufficiency in Adults After Childhood Bacterial Meningitis
    1 Supplementary Online Content Roed C, Omland LH, Skinhoj P, Rothman KJ, Sorensen HT, Obel N. Educational achievement and economic self-sufficiency in adults after childhood bacterial meningitis. JAMA. doi:10.1001/jama.2013.3792 Appendix 1. Description of Registries Appendix 2. Diagnosis Codes for Intrauterine and Birth Asphyxia or Chromosomal Abnormalities Appendix 3. Diagnosis Codes for Meningococcal, Pneumococcal, Or H influenzae Meningitis Appendix 4. Diagnosis Codes for Neuroinfections Other Than Bacterial Meningitis eTable 1. Number of Events in the Study Population and Total Observation Time eTable 2. Estimated Prevalence at Age 35 of Vocational Education, High School, Higher Education, Economic Self‐sufficiency and Disability pension Among Meningitis Patients, Members of the Population Comparison Cohorts, and Their Siblings Without Neonatal Morbidity eFigure 1. Cumulative Incidence of Having Been Economically Self‐sufficient for a Year and of Receiving Disability Pension in the Meningococcal, Pneumococcal and H. influenzae Meningitis Patients (Black), Members of the Population Comparison Cohort (Red), Full Siblings of Patients (Green) and Siblings of Members of the Population Comparison Cohort (Blue) eFigure 2. Cumulative Incidence of Vocational Education, High School and Higher Education for Meningococcal, Pneumococcal and H. influenzae Meningitis Patients (Black), Members of the Population Comparison Cohort (Red), Full Siblings of Patients (Green) and Full Siblings of Members of the Population Comparison Cohort (Blue) Born Before 1980 eFigure 3. Cumulative Incidence of Vocational Education, High School and Higher Education for Meningococcal, Pneumococcal and H. influenzae Meningitis Patients (Black), Members of the Population Comparison Cohort (Red), Full Siblings of Patients (Green) and Full Siblings of Members of the Population Comparison Cohort (Blue) Born After 1980 This supplementary material has been provided by the authors to give readers additional information about their work.
    [Show full text]
  • NIPT Fact Sheet
    Victorian Clinical Genetics Services Murdoch Childrens Research Institute The Royal Children's Hospital Flemington Road, Parkville VIC 3052 P (03) 8341 6201 W vcgs.org.au NIPT fact sheet High risk for XXY This fact sheet is for women and their partners who receive a high risk result for XXY from the perceptTM non-invasive prenatal test (NIPT) Possible explanations for this offered by Victorian Clinical Genetics Services (VCGS). This information high risk result: may not be applicable to test results reported by other NIPT service There is a high chance that the baby has XXY. providers. However, the only way to provide a definitive As part of the service offered by VCGS, women and couples have diagnosis is to have a diagnostic procedure the opportunity to discuss their result with a genetic counsellor at no (CVS or amniocentesis) with chromosome additional cost. Genetic counsellors are experts in assisting people to testing. understand genetic test results and make informed decisions about In some cases, high risk results for XXY may further testing options. represent ‘false positive’ test results. A false positive result means that although NIPT indicates a high risk of XXY, the baby does not What does this result mean? have this condition. NIPT is a way for women to get an accurate estimate of the chance that their baby has one of the most common chromosome conditions: Possible causes of false positive results trisomy 21 (Down syndrome), trisomy 18 and trisomy 13. The test for XXY from NIPT include: may also detect whether there are extra or missing copies of the sex chromosomes, X and Y.
    [Show full text]
  • ALS and Other Motor Neuron Diseases Can Represent Diagnostic Challenges
    Review Article Address correspondence to Dr Ezgi Tiryaki, Hennepin ALS and Other Motor County Medical Center, Department of Neurology, 701 Park Avenue P5-200, Neuron Diseases Minneapolis, MN 55415, [email protected]. Ezgi Tiryaki, MD; Holli A. Horak, MD, FAAN Relationship Disclosure: Dr Tiryaki’s institution receives support from The ALS Association. Dr Horak’s ABSTRACT institution receives a grant from the Centers for Disease Purpose of Review: This review describes the most common motor neuron disease, Control and Prevention. ALS. It discusses the diagnosis and evaluation of ALS and the current understanding of its Unlabeled Use of pathophysiology, including new genetic underpinnings of the disease. This article also Products/Investigational covers other motor neuron diseases, reviews how to distinguish them from ALS, and Use Disclosure: Drs Tiryaki and Horak discuss discusses their pathophysiology. the unlabeled use of various Recent Findings: In this article, the spectrum of cognitive involvement in ALS, new concepts drugs for the symptomatic about protein synthesis pathology in the etiology of ALS, and new genetic associations will be management of ALS. * 2014, American Academy covered. This concept has changed over the past 3 to 4 years with the discovery of new of Neurology. genes and genetic processes that may trigger the disease. As of 2014, two-thirds of familial ALS and 10% of sporadic ALS can be explained by genetics. TAR DNA binding protein 43 kDa (TDP-43), for instance, has been shown to cause frontotemporal dementia as well as some cases of familial ALS, and is associated with frontotemporal dysfunction in ALS. Summary: The anterior horn cells control all voluntary movement: motor activity, res- piratory, speech, and swallowing functions are dependent upon signals from the anterior horn cells.
    [Show full text]
  • Neuropsychological Testing
    Medical Coverage Policy Effective Date ............................................. 8/15/2021 Next Review Date ....................................... 8/15/2022 Coverage Policy Number .................................. 0258 Neuropsychological Testing Table of Contents Related Coverage Resources Overview .............................................................. 1 Attention-Deficit/Hyperactivity Disorder: Assessment Coverage Policy ................................................... 1 and Treatment General Background ............................................ 2 Autism Spectrum Disorder/Pervasive Developmental Medicare Coverage Determinations .................. 15 Disorders: Assessment and Treatment Coding/Billing Information .................................. 16 Cognitive Rehabilitation Lyme Disease Treatment— Antibiotic Treatment References ........................................................ 28 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary
    [Show full text]
  • Approach to a Patient with Hemiplegia and Monoplegia
    CHAPTER Approach to a Patient with Hemiplegia and Monoplegia 27 Sudhir Kumar, Subhash Kaul INTRODUCTION 4. Injury to multiple cervical nerve roots. Monoplegia and hemiplegia are common neurological 5. Functional or psychogenic. symptoms in patients presenting to the emergency department as well as outpatient department. Insidious onset, gradually progressive monoplegia affecting lower limb can be caused by the following Monoplegia refers to weakness of one limb (either arm or conditions: leg) and hemiplegia refers to weakness of one arm and leg on the same side of body (either left or right side). 1. Tumor of the contralateral frontal lobe. There are a variety of underlying causes for monoplegia 2. Tumor of spinal cord at thoracic or lumbar level. and hemiplegia. The causes differ in different age groups. 3. Chronic infection of brain (frontal lobe) or spinal The causes also differ depending on the onset, progression cord (thoracic or lumbar level), such as tuberculous. and duration of weakness. Therefore, one needs to adopt a systematic approach during history taking and 4. Lumbosacral-plexopathy, due to diabetes mellitus. examination in order to arrive at the correct diagnosis. Insidious onset, gradually progressive monoplegia, Appropriate investigations after these would confirm the affecting upper limb, can be caused by one of the following diagnosis. conditions: The aim of this chapter is to systematically look at the 1. Tumor of the contralateral parietal lobe. differential diagnosis of monoplegia and hemiplegia and outline the approach needed to pinpoint the exact 2. Compressive lesion (tumor, large disc, etc) in underlying cause. cervical cord region. 3. Chronic infection of the brain (parietal lobe) or APPROACH TO THE DIAGNOSIS OF MONOPLEGIA spinal cord (cervical region), such as tuberculous.
    [Show full text]
  • Molecular Detection of Human Parasitic Pathogens
    MOLECULAR DETECTION OF HUMAN PARASITIC PATHOGENS MOLECULAR DETECTION OF HUMAN PARASITIC PATHOGENS EDITED BY DONGYOU LIU Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2013 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Version Date: 20120608 International Standard Book Number-13: 978-1-4398-1243-3 (eBook - PDF) This book contains information obtained from authentic and highly regarded sources. Reasonable efforts have been made to publish reliable data and information, but the author and publisher cannot assume responsibility for the validity of all materials or the consequences of their use. The authors and publishers have attempted to trace the copyright holders of all material reproduced in this publication and apologize to copyright holders if permission to publish in this form has not been obtained. If any copyright material has not been acknowledged please write and let us know so we may rectify in any future reprint. Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc.
    [Show full text]